Skip to content

Clinical trials

Terminated Phase 3 trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 3 Status: Terminated Country / region: South Korea Clear all

367 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20043
20054
20064
200716
200818
200914
201019
201116
201222
201316
201425
201516
201617
201719
201834
201920
202024
202134
202229
20237
20248

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated367

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Hoffmann-La Roche29
Novartis Pharmaceuticals26
Pfizer22
GlaxoSmithKline19
Sanofi13
Eli Lilly and Company11
Janssen Research & Development, LLC10
Amgen9
Merck Sharp & Dohme LLC9
Gilead Sciences8

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung26
Alzheimer Disease24
Diabetes Mellitus, Type 214
Breast Neoplasms13
Neoplasms13
Crohn Disease12
Neoplasm Metastasis11
Arthritis, Rheumatoid9
Dementia8
Stomach Neoplasms8

Trials

Showing 1 to 25 of 367. Each trial links to its page on Pharma Observatory.

267 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.